The invention relates generally to systems for facilitating patient medication compliance, and more particularly to apparatus and methods for administering individual doses of therapeutic products to a patient in a non-sequential fashion. The invention allows dosage amounts to be tailored to accommodate fluid medical conditions.
In the existing pharmaceutical dispensing systems, prescriptions are filled in either standard thirty day or sixty day allotments. With such systems, there is no accurate way to inventory pharmaceuticals and/or to audit patient compliance with a pharmacist's or physician's instructions or consumption of the product. This is due in part to the fact that the pharmaceuticals are dispensed in a lot, and not every pill or dose is separately bar coded and traceable.
Certain medications are supplied as part of a foil or paper wrapped blister pack containing a plurality of individual unit doses. A number of devices have been developed to assist a physician, pharmacist, nurse or other medical personnel in administering unit doses contained in a standard blister pack. U.S. Pat. No. 5,489,025 to Romick and U.S. Pat. No. 6,540,081 to Balz et al. are examples of such devices. Romick discloses a medication dispenser having a top plate with at least one aperture for receiving the blister portion of a blister pack, a bottom plate adapted to engage the top plate so as to confine the blister pack between the plates and having at least one aperture in register with the blister portion, and a bridge spanning the top plate and supported by support members. Balz et al. discloses a dispenser for dispensing a unit dose of a solid product contained in a blister pack. The dispenser includes a housing, a back plate, and a dispensing tray. The blister pack containing product is positioned between the housing and the back plate, whereby the product is dispensed through the back plate into the dispensing tray where it can be acquired for use. A puncture tab is integrated into the back plate for aiding in rupturing the backing of the blister pack to dispense the product more easily.
Although these devices decrease the likelihood of errors in the administration of medication in a health care facility by organizing the blister packs so as to prevent the unit doses from exiting the blister portion until the foil backing of the blister pack is ruptured, the subject devices suffer from a number of limitations. Primarily, the devices are not intended for holding a plurality of different medications and/or varying dosages prescribed as part of a complex treatment regimen. In the existing blister pack holders, medicaments are organized chronologically, according to their respective times of administration. As such, the existing blister pack holders are limited in their ability to provide the flexible dosage administration that is required for situations where the patient's regimen is the subject of frequent dosage adjustments or the patient is prescribed more than one medication to be administered at varying times over the course of a day or over the course of several weeks or months.
Moreover, the conventional designs are not suited for use by a patient in a home, assisted living facility, or other setting remote from the support of health care professionals. As described above, the existing blister pack holders organize medicaments chronologically, according to their respective times of administration. However, they fail to provide a mechanism by which a prescribed medication or dosage can be remotely adjusted in real-time, in response to an unexpected change in a patient's health condition. There is often a delay of several hours, and in some cases, several days, before a patient is able to take a new medication or dosage. During this period, the patient may be confused as to the correct dosing regimen and continue to take doses according to the predetermined sequence provided in the blister pack. In addition, because a new prescription and allotment of blister packs is required every time a dose is adjusted, the patient is must travel to a physician's office and pharmacy. This is particularly disadvantageous to mobility-impaired patients and is a major source of drug non-compliance. Frequently the patient's condition deteriorates, as the patient is unable to continue his/her course of treatment.
An additional shortcoming of the existing medication holders is that they are relatively complicated, requiring manufacture and assembly of various moveable parts. A still further shortcoming of conventional containers and storage devices is that they do not provide a practical means of quickly inventorying the exact amount of medication remaining in a prescription, and the amount of medication consumed by a patient.
In view of the above shortcomings, there is a need for a convenient device for storing and inventorying various therapeutic products and/or varying dosages prescribed as part of a complex treatment regimen.
A universal medication carrier is provided for enabling a patient or healthcare practitioner to non-sequentially store, inventory, administer and deliver sealed unit dose packages containing therapeutic products, in accordance with a prescribed treatment regimen. The medication carrier comprises a receptacle having a plurality of stalls for retaining a sealed unit dose package, wherein each stall includes a partial cover, sidewalls and an opening. The stall further includes retaining means for holding the sealed unit dose package within the stall until a scheduled dosing time. The medication carrier enables identifying indicia imprinted on the surface of each unit dose package by a drug manufacturer to be readily examined, enabling the patient or healthcare practitioner to conveniently and non-consecutively access an appropriate therapy.
Accordingly, it is an object of the present invention to provide a medication carrier for non-sequentially storing a plurality of individually sealed unit dose packages containing different medications and/or varying dosage strengths.
A further object of the invention is to provide a medication carrier that is conveniently sized so as to be storable in multiple quantities in a container for ease of administering or delivering by a user, such as a physician.
A still further object of the invention is to provide a medication carrier that enables a patient remotely located from a healthcare facility to administer or deliver any one of a plurality of unit dose packages containing different medications and/or varying dosages, in any order, without being limited by a predetermined sequence and without dislodging other doses contained within the medication carrier.
An additional object of the invention is to provide a medication carrier that facilitates compliance with a complicated prescription regimen in which dosing amounts change over time.
Another object of the present invention is to provide a medication carrier that reduces medication waste by eliminating the need for a patient remotely located from a healthcare facility to discard doses or obtain a new prescription, in the event of a dose adjustment.
Yet another object of the present invention is to provide a medication carrier that allows a patient's therapeutic regimen to be precisely monitored and enables a healthcare facility to accurately track and account for each unit dose package of medication at all times.
Other objects of the invention will become apparent from the following description of the invention.
a, 1b and 1c are perspective views of medication carriers containing 32, 20 and 16 stalls, respectively, for accommodating different sized unit dose packages, in accordance with the present invention.
a is an assembly view depicting a medication carrier incorporating protrusions for retaining the unit dose packages, in accordance with one embodiment of the invention.
b and 4d are bottom views of the medication carrier illustrated in
a is an assembly view depicting a medication carrier incorporating generally triangular retaining means for securing the unit dose packages, in accordance with one embodiment of the invention.
a is an assembly view showing a dual unit medication carrier incorporating rounded tabs for retaining the unit dose packages, in accordance with one embodiment of the invention.
a is an assembly view depicting a medication carrier incorporating fasteners for retaining the unit dose packages, in accordance with one embodiment of the invention.
a and 12a are bottom views of a medication carrier incorporating generally triangular retaining means. Cross-sectional views of an individual stall of each carrier are provided in
a shows a bottom view of a medication carrier with generally cylindrical tabs, wherein each pair of tabs includes at least one dimple for holding a unit dose package firmly in place. Cross-sectional views of the dimpled tabs are provided in
In accordance with the present invention, a universal medication carrier 12, 35 is provided for allowing patients and healthcare professionals to non-consecutively administer or deliver unit dose packages 21 in accordance with a prescribed treatment regimen, without being limited by a predetermined sequence or serial delivery restriction. The medication carrier 12, 35 comprises a receptacle having top and bottom surfaces and a series of partially open stalls 11 interposed therein, each stall being suitably sized to receive a unit dose package 21. Standard unit dose packages normally include a plastic bubble 24 for holding the therapeutic product and a pierceable seal 25 fabricated from paper or foil laminate for retaining the product within the bubble 24. An electronic identifier code 36, such as a bar code or radio frequency identification tag, and human-readable information (collectively referred to hereafter as “identifying indicia”) is imprinted on the seal 25 of the unit dose package 21. The identifying indicia faces upwardly in each stall 11, enabling a patient or healthcare practitioner to easily view and select an appropriate unit dose therapy. The design of the medication carrier 12, 35 allows each unit dose package 21 to be non-consecutively accessed and released from the stall 11 in response to manual or automated extraction, without disrupting the other packages.
The medication carrier 12, 35 is preferably rectilinear and planar for most uses thereof, as the planar design allows for ease of product inventorying, storage, and transportation. Other surfaces and geometries may be employed, however, such as curved or cubic designs, as may be appropriate for certain medications. The medication carrier 12, 35 is preferably made of thin plastic, although metal, cardboard or other suitable material which allows the carrier to be light weight, durable and easily moldable may be employed. As shown in
a and 1c illustrate medication carriers having 20 and 16 stalls, respectively, sized and shaped to accommodate larger medication packages. It will be understood that the term “medication” as used herein is intended to include individual, unit-of-issue doses of prescription and non-prescription medications, medical supplies, pharmaceuticals, nutraceuticals, diagnostic materials and other therapeutic products, in both solid and liquid dosage forms. Specific examples include suppositories, prefilled syringes, inhalers, lotions, suspensions, blood testing strips, pills, tablets and capsules.
Referring now to
As illustrated in
Upon insertion of the unit dose package 21, the plastic bubble 24 containing the medication extends into a central area of the stall 11, while peripheral edges of the package seal 25 extend above retaining means 19, 20 that protrude from opposing sidewalls 15, 17 of the stall. The retaining means comprises two or more generally horizontal protrusions 19, 20, the protrusions being in substantial alignment and being integrally molded with or otherwise formed in opposing sidewalls 15, 17 of the stall 11, proximate the closure 13, such that the seal 25 of the unit dose package is confined between the protrusions 19, 20 and the closure. As a result, the unit dose package 21 is held firmly in place until the dose is administered or delivered to a patient. This orientation also permits an electronic code and other indicia imprinted on the upwardly facing seal 25 of the unit dose package 21 to be read through the portal 37. The retaining means 19, 20 may be modified to accommodate different sizes of unit dose packages 21. For instance, heavier medications such as liquids and gels may require retaining means of thicker gauge and size. The protrusions 19, 20 are suitably designed and spaced to avoid crushing the medication contained within the plastic bubble 24 or otherwise interfere with insertion of the unit dose package 21 into the stall 11.
When a unit dose package 21 is to be administered or delivered, pressure is applied to either the outer surface of the closure 13 of the stall 11 containing the desired dose or to the exposed surface of the package seal 25 framed within the open portal 37. As a result, the package seal 25 is pushed against the protrusions 19, 20, whereby the edges of the seal 25 bend causing the entire unit dose package 21 to drop out of the medication carrier 12, through the open side 38. As mentioned above, pressure may be applied through both manual and automated means. In either case, ejection of the fully intact unit dose package 21 from a stall 11 of the medication carrier 12 does not serve to dislodge, or in any way disrupt, the other unit dose packages contained in the carrier. If desired, a unit dose package 21 may be acquired from the bottom surface 22 of the medication carrier 12 by simply removing the package 21 from its stall 11, through the opening 38. When the unit dose packages are depleted, the medication carrier 12 is loaded with a fresh supply of doses by placing a new package 21 into each vacant stall 11 of the carrier through a corresponding opening 38.
Referring now to
The support frame 26 is provided with a series of clearance slots 28 appropriately sized to coalesce with the stalls 11 of the receptacle 33 for insertion and removal of the unit dose packages 21. Retaining means, comprising a deflectable flap or tab 29, 34, preferably protrude from opposing, interior surfaces 32 flanking each clearance slot to prevent the unit dose package 21 from exiting the open side 38 of the stall 11 until a scheduled dosing time. For purposes of illustration,
The support frame 26 may be attached to the bottom surface 22 of the receptacle 33 by means of any suitable coupling. As illustrated in
When the receptacle 33 and support frame 26 of the medication carrier 35 are assembled, the tabs 29, 34 are superimposed under each stall 11 of the receptacle 33, in a generally horizontal fashion. In this manner, the tabs 29, 34 supportably engage the unit dose package 21 and prevent the package from being prematurely expelled from the medication carrier 35. Consequently, the unit dose package 21 is retained within the medication carrier 35, between the closure 13 and subjacent tabs 29, 34 of the support frame 26, until a patient's scheduled dosing time. When a unit dose package 21 is to be administered or delivered, pressure is placed on the stall 11 containing the desired dose through manual or automated means. As the pressure is applied, the tabs 29, 34 deflect, causing the sealed unit dose package 21 to be expelled from the medication carrier 35, without disrupting the other packages. The desired dose can also be acquired by separating the tabs 29, 34 to expose and easily retrieve the unit dose package 21. When the unit dose packages 21 are depleted, a fresh supply is loaded into the medication carrier 35 by simply separating the tabs 29, 34 and inserting the new packages 21 into empty stalls 11 of the carrier 35.
As previously discussed, a principal feature of the universal medication carrier 12, 35 is its ability to administer and deliver the unit dose/unit-of-issue packages 21 in non-consecutive order, without being limited by a predetermined sequence, enabling a patient's medication regimen to be appropriately tailored to adapt to fluid medical conditions. As such, the unit dose packages 21 need not be loaded into the medication carrier 12, 35 in any particular order. This overcomes a significant drawback associated with existing devices, in that medicaments must be organized chronologically, according to their respective times of administration. Most notably, the existing medication holders are not designed for storing individual unit dose packages. Rather, they are configured for use with a blister pack containing multiple doses of a single medication, wherein each of the doses within the blister pack is identical in form and strength.
In the present invention, unit dose packages 21 are retained as discrete components, not as part of an integral blister pack. As illustrated in
In operation, a pharmacist, nurse, or other healthcare practitioner places individual unit dose packages 21 containing a prescribed course of medication for a particular patient into the stalls 11 of the medication carrier 12, 35, in any order, as described above. The unit dose packages 21, which may contain varying dosage strengths of a specific medication and/or different medications, need not be organized chronologically, as is required in the existing designs, since each unit dose package 21 is independently accessed and retrieved. In most cases, the healthcare practitioner affixes a label containing an electronic code 36 to an empty stall 11 of the medication carrier 12, 35. The electronic code 36 identifies the patient, his/her dosing regimen, and inventory of medications contained within the carrier 12, 35. The encoded data is programmed into a computer terminal, enabling the practitioner to accurately track and account for each unit dose package 21 at all times.
For use of the invention in a hospital, clinic, long-term care facility or other location in which medical personnel are based, the medication carrier 12, 35 is normally stored until the patient's scheduled dosing time. At the designated time, the healthcare practitioner inspects the unit dose package seals 25, which are conveniently oriented in plain view within the medication carrier 12, 35, in order to select a desired medication. The unobstructed, open design of the present invention allows the practitioner to easily locate the unit dose package 21 containing such medication. Prior to administering or delivering the dose to the patient, the healthcare practitioner scans the electronic code on the package seal 25 and/or the carrier label 36 in order to update the patient's records. Thereafter, the practitioner simply pushes the sealed unit dose package 21 out of the medication carrier 12, 35 in the manner described above.
The universal medication carrier 12, 35 of the present invention is particularly suited for use by a patient in a home, assisted living facility, or other ambulatory setting. As previously discussed, unit dose packages 21 are administered or delivered to the patient on a unit dosage basis, and each dose is inventoried with its own bar code. Various medications or different dosages of the same medication may be administered or delivered as part of the same prescription period (
The present invention also serves as a medication management and compliance tool that ensures the accurate delivery of both custom packaged and commercially available sealed unit dose and unit-of-issue therapeutic products to a patient. Moreover, the invention fosters compliance with a prescribed treatment regimen by, for example, ensuring that the patient remains within recommended therapeutic levels.
In the event of a change in the health condition of the patient, or other situation requiring a dosage change, a healthcare practitioner can readily adjust the prescribed dosage, in real-time, without the need for a new prescription. The healthcare practitioner simply reviews the stored inventory record of medications contained within the patient's medication carrier 12, 35 and directs the patient to take a different medication or dosage having a higher or lower strength, as appropriate. As previously discussed, the design of the universal medication carrier 12, 35 allows therapeutic products to be administered to the patient in non-consecutive order, without any sequential delivery restrictions. Therefore, dosing changes can be made by the remotely located practitioner without any disruption to the patient's course of treatment.
A principal advantage of the subject invention, therefore, is its ability to administer and deliver diverse types of medications non-consecutively, enabling a patient's medication regimen to be appropriately tailored to adapt to fluid medical conditions. Because different medications of varying dosages are immediately available to the patient, the patient is spared the inconvenience of traveling to a physician's office and/or to a pharmacy to obtain the requisite medication. This feature is particularly important with respect to mobility impaired patients. Furthermore, patient expenses are reduced since the new dosage is already on hand and need not be purchased.
The present system provides other significant advantages over the prior art. As previously mentioned, with existing medication dispensing systems, there is no accurate way to inventory pharmaceuticals and/or to audit patient compliance or consumption of the dispensed products. This is due, in part, to the fact that the pharmaceuticals are dispensed in a lot, whereby not every pill or dose is separately encoded and traceable. In the present invention, delivery and administration of medication occurs on a unit dosage basis, whereby each individual dose is inventoried with its own electronically coded identifier, allowing a healthcare practitioner to accurately monitor patient compliance with a prescribed treatment regimen.
In the subject invention, the patient avoids purchasing an unnecessary number of doses and only purchases the number of units required for the prescribed regimen. This is to be contrasted with existing systems, in which prescriptions are normally filled in standard thirty day or sixty day allotments. In this regard, the present invention reduces the incidence of medication waste by supplying only necessary doses to the patient rather than an aggregate number of doses, which are ultimately discarded. As a result, managed care providers and other third party payors realize significant cost savings.
With the rise of telehealth and telepharmacy services, an increased level of responsibility is being placed upon patients and caregivers in the administration and delivery of therapeutic products without the support of a healthcare practitioner. The present system enables the healthcare practitioner to change or adjust a patient's dosage in real time, increasing the likelihood that the patient will adhere to a prescribed treatment regimen. This is a tremendous advantage over existing systems, which allow a remotely based practitioner to communicate a change in dosing amount to the patient, but do not enable the practitioner to change or adjust the prescribed dosage in real time. A further advantage of the system is that dosages remain completely sealed until the point of administration or delivery to a patient, thereby avoiding the medication contamination and degradation problems that plague medication containers known in the art.
While the invention has been particularly shown and described with reference to preferred embodiments thereof, it will be understood by those skilled in the art that various alterations in form and detail may be made therein without departing from the spirit and scope of the invention. In particular, while the invention illustrated by the Figures shows a specific size and shape of the medication carrier 12, 35, these parameters can vary considerably and are not limited by the preferred embodiments described herein as depicted in the Figures.
Additionally, while this application generally addresses use of the universal medication carrier to inventory, store, administer and deliver medicaments, such use is by no means limited to this application. The carrier 12, 35 provided herein can be adapted for use with a variety of agents such as nutraceuticals, cosmetics and small mechanical elements. Furthermore, the medication carrier may be used in connection with an automated medication delivery system.
This application claims the benefit of U.S. Provisional Patent Application No. 60/565,220 filed Apr. 24, 2004.
Number | Name | Date | Kind |
---|---|---|---|
1935595 | Clark | Nov 1933 | A |
2288341 | Hendrik et al. | Jun 1942 | A |
2440930 | Gugllelmo | May 1948 | A |
2825651 | Lee et al. | Mar 1958 | A |
3073885 | Gugllelmo | Jan 1963 | A |
3143207 | Wagner | Aug 1964 | A |
3233198 | Schrader et al. | Feb 1966 | A |
3329080 | Reach | Jul 1967 | A |
3351192 | La Plante | Nov 1967 | A |
3390766 | Stockdale | Jul 1968 | A |
3482733 | Groves | Dec 1969 | A |
3503493 | Nagy | Mar 1970 | A |
3563405 | Zaremski | Feb 1971 | A |
3626080 | Pierce | Dec 1971 | A |
3809221 | Compere | May 1974 | A |
3876268 | Colver | Apr 1975 | A |
3902146 | Muralidharan | Aug 1975 | A |
4019793 | Gerding | Apr 1977 | A |
4019996 | Jay et al. | Apr 1977 | A |
4053941 | Tokihlko et al. | Oct 1977 | A |
4054207 | Lazure et al. | Oct 1977 | A |
4085395 | Billerbeck et al. | Apr 1978 | A |
4108789 | Jay et al. | Aug 1978 | A |
4142933 | Jay et al. | Mar 1979 | A |
4147021 | Kondo | Apr 1979 | A |
4148273 | Hollingsworth et al. | Apr 1979 | A |
4165709 | Studer | Aug 1979 | A |
4166807 | Inoue et al. | Sep 1979 | A |
4176762 | Krakauer et al. | Dec 1979 | A |
4177156 | Bonhomme | Dec 1979 | A |
4187327 | Lapp et al. | Feb 1980 | A |
4211665 | Pellegrini, Jr. | Jul 1980 | A |
4238343 | Pellegrini, Jr. | Dec 1980 | A |
4256264 | Mandelcorn et al. | Mar 1981 | A |
4256591 | Yamamoto et al. | Mar 1981 | A |
4259706 | Mandelcorn | Mar 1981 | A |
4276184 | Mandelcorn et al. | Jun 1981 | A |
4282106 | Schaap et al. | Aug 1981 | A |
4290926 | Shaw | Sep 1981 | A |
4294715 | Klein et al. | Oct 1981 | A |
4320034 | Lapp | Mar 1982 | A |
4343029 | Renga et al. | Aug 1982 | A |
4347169 | Sato et al. | Aug 1982 | A |
4355346 | Gauger et al. | Oct 1982 | A |
4384972 | Nakamura et al. | May 1983 | A |
4413674 | Avery et al. | Nov 1983 | A |
4427561 | Kusayanagi et al. | Jan 1984 | A |
4437082 | Walsh et al. | Mar 1984 | A |
4462696 | Yung et al. | Jul 1984 | A |
4467305 | Ando | Aug 1984 | A |
4493943 | Sato et al. | Jan 1985 | A |
4511949 | Shedigian | Apr 1985 | A |
4530782 | Meyer | Jul 1985 | A |
4536331 | Shedigian | Aug 1985 | A |
4543207 | Sato et al. | Sep 1985 | A |
4549034 | Sato et al. | Oct 1985 | A |
4566994 | Hasegawa et al. | Jan 1986 | A |
4570043 | Lloyd et al. | Feb 1986 | A |
4572403 | Benaroya | Feb 1986 | A |
4573580 | Messer | Mar 1986 | A |
4600119 | Olson | Jul 1986 | A |
4618914 | Sato et al. | Oct 1986 | A |
4621302 | Sato et al. | Nov 1986 | A |
4621980 | Reavely et al. | Nov 1986 | A |
4623953 | Dakin | Nov 1986 | A |
4627192 | Fick | Dec 1986 | A |
4681302 | Thompson | Jul 1987 | A |
4681980 | Sato et al. | Jul 1987 | A |
4695954 | Rose et al. | Sep 1987 | A |
4702966 | Farrell et al. | Oct 1987 | A |
4725997 | Urquhart et al. | Feb 1988 | A |
4733797 | Haber | Mar 1988 | A |
4734824 | Sato et al. | Mar 1988 | A |
4738780 | Atwood | Apr 1988 | A |
4744000 | Mason et al. | May 1988 | A |
4744905 | Atwood | May 1988 | A |
4745966 | Avery | May 1988 | A |
4747447 | Scanlan et al. | May 1988 | A |
4748600 | Urquhart | May 1988 | A |
4763810 | Christiansen | Aug 1988 | A |
4768177 | Kehr et al. | Aug 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4785981 | Rodman | Nov 1988 | A |
4806276 | Maier | Feb 1989 | A |
4828703 | Atwood | May 1989 | A |
4834257 | Book et al. | May 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4846163 | Bannister, Jr. et al. | Jul 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4872591 | Konopka | Oct 1989 | A |
4911327 | Shepherd et al. | Mar 1990 | A |
4929784 | Klinkmann et al. | May 1990 | A |
4933873 | Kaufman et al. | Jun 1990 | A |
4953745 | Rowlett, Jr. | Sep 1990 | A |
4967043 | Killarney | Oct 1990 | A |
4970669 | McIntosh et al. | Nov 1990 | A |
4990718 | Pelrine | Feb 1991 | A |
5036462 | Kaufman et al. | Jul 1991 | A |
5047948 | Turner | Sep 1991 | A |
5072430 | Dahlstrosm et al. | Dec 1991 | A |
5077069 | Chang et al. | Dec 1991 | A |
5082113 | Romick | Jan 1992 | A |
5084826 | Kaufman et al. | Jan 1992 | A |
5102008 | Kaufman et al. | Apr 1992 | A |
5102659 | Hudson | Apr 1992 | A |
D328133 | Kaufman et al. | Jul 1992 | S |
5142484 | Kaufman et al. | Aug 1992 | A |
5143763 | Yamada et al. | Sep 1992 | A |
5148944 | Kaufman et al. | Sep 1992 | A |
5159527 | Flynn | Oct 1992 | A |
5159581 | Agans | Oct 1992 | A |
5171918 | Shubkin et al. | Dec 1992 | A |
5176285 | Shaw | Jan 1993 | A |
5180518 | Sugihara et al. | Jan 1993 | A |
5197632 | Kaufman et al. | Mar 1993 | A |
5230441 | Kaufman et al. | Jul 1993 | A |
5250750 | Shubkin et al. | Oct 1993 | A |
5259978 | Yoshimura et al. | Nov 1993 | A |
5260077 | Carrick et al. | Nov 1993 | A |
5267174 | Kaufman et al. | Nov 1993 | A |
5291191 | Moore | Mar 1994 | A |
5323920 | Harris et al. | Jun 1994 | A |
5329459 | Kaufman et al. | Jul 1994 | A |
5336423 | Pialet et al. | Aug 1994 | A |
5367505 | Tsuchiya et al. | Nov 1994 | A |
5368187 | Poncetta et al. | Nov 1994 | A |
5377839 | Relyea et al. | Jan 1995 | A |
5392952 | Bowden | Feb 1995 | A |
5400301 | Rackley | Mar 1995 | A |
5405011 | Haber et al. | Apr 1995 | A |
5408443 | Weinberger | Apr 1995 | A |
5409443 | Zabriskie et al. | Apr 1995 | A |
5412372 | Parkhurst et al. | May 1995 | A |
5429761 | Havelka et al. | Jul 1995 | A |
5431299 | Brewer et al. | Jul 1995 | A |
5439648 | Balderson et al. | Aug 1995 | A |
5442728 | Kaufman et al. | Aug 1995 | A |
5451334 | Bongardt et al. | Sep 1995 | A |
5469025 | Romick | Nov 1995 | A |
5472113 | Shaw | Dec 1995 | A |
5489025 | Romick | Feb 1996 | A |
5538654 | Lawate et al. | Jul 1996 | A |
5570810 | Lambelet, Jr. et al. | Nov 1996 | A |
5571492 | Yao et al. | Nov 1996 | A |
5593390 | Castellano et al. | Jan 1997 | A |
5609268 | Shaw | Mar 1997 | A |
5623242 | Dawson, Jr. et al. | Apr 1997 | A |
5646912 | Cousin | Jul 1997 | A |
5657236 | Conkright | Aug 1997 | A |
5703786 | Conkright | Dec 1997 | A |
5710551 | Ridgeway | Jan 1998 | A |
5755357 | Orkin et al. | May 1998 | A |
5850344 | Conkright | Dec 1998 | A |
5878855 | Wangu et al. | Mar 1999 | A |
5945651 | Chorosinski et al. | Aug 1999 | A |
5963136 | O'Brien | Oct 1999 | A |
5971594 | Sahai et al. | Oct 1999 | A |
6004020 | Bartur | Dec 1999 | A |
6021918 | Dumont et al. | Feb 2000 | A |
6082544 | Romick | Jul 2000 | A |
6138865 | Gilmore | Oct 2000 | A |
6150942 | O'Brien | Nov 2000 | A |
6155454 | George et al. | Dec 2000 | A |
6161095 | Brown | Dec 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6198383 | Sekura et al. | Mar 2001 | B1 |
6202642 | McKinnon et al. | Mar 2001 | B1 |
6234343 | Papp | May 2001 | B1 |
6375225 | Lapsker | Apr 2002 | B1 |
6375956 | Hermelin et al. | Apr 2002 | B1 |
6439422 | Papp et al. | Aug 2002 | B1 |
6540081 | Balz et al. | Apr 2003 | B2 |
6574166 | Niemiec | Jun 2003 | B2 |
6601729 | Papp | Aug 2003 | B1 |
6848593 | Papp | Feb 2005 | B2 |
6951353 | Kozlowski et al. | Oct 2005 | B2 |
6973371 | Benouali | Dec 2005 | B1 |
20030042167 | Balz et al. | Mar 2003 | A1 |
20030042169 | Caporali et al. | Mar 2003 | A1 |
20030057230 | Stevens et al. | Mar 2003 | A1 |
20030102247 | Inoue et al. | Jun 2003 | A1 |
20030209558 | Cross | Nov 2003 | A1 |
20050087473 | Fabricius et al. | Apr 2005 | A1 |
20050150897 | Fabricius et al. | Jul 2005 | A1 |
20050237222 | Bogash | Oct 2005 | A1 |
20050240305 | Bogash et al. | Oct 2005 | A1 |
20050256830 | Siegel et al. | Nov 2005 | A1 |
20050274643 | Arnold | Dec 2005 | A1 |
Number | Date | Country |
---|---|---|
1363579 | Nov 2003 | EP |
2343440 | May 2000 | GB |
2004002396 | Jan 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20050237222 A1 | Oct 2005 | US |
Number | Date | Country | |
---|---|---|---|
60565220 | Apr 2004 | US |